recall
saveChiesi USA, Inc. recall (Cls II)
April 1, 2026updated 2mo ago
community read0 votes
CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03. — Reason: Lack of Assurance of Sterility — Status: Ongoing
view source ↗